# Preop Dexmedetomidine Attenuates Haemodynamic Responses to Hydrodissection

> **NCT02102139** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 41 (actual)

## Conditions studied

- Robotic Thyroidectomy

## Interventions

- **DRUG:** DXM + Propofol
- **DRUG:** Saline + Propofol

## Key facts

- **NCT ID:** NCT02102139
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02102139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02102139, "Preop Dexmedetomidine Attenuates Haemodynamic Responses to Hydrodissection". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02102139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*